Usted está aquí

Inicio / 1%

Immunotherapeutic combination for the treatment of tumors that overexpress receptors with kinase activity in tyrosine residues.

Combinación inmunoterapéutica para el tratamiento de tumores que sobre-expresan receptores con actividad quinasa en residuos de tirosina.

Superior Efficacy and Safety of a Nonemulsive Variant of the NGcGM3/VSSP Vaccine in Advanced Breast Cancer Patients.

Analysis of the influence of LONG R3 IGF-1 growth factor in cell cultures using the CHO cell line.

Usefulness of the ACEF scale to predict the occurrence of postoperative complications in myocardial revascularization surgery

Experiences of a clinical trial in primary health care for evaluation of a vaccine in the treatment of lung cancer.

Prognostic significance of N-Glycolyl GM3 ganglioside expression in non-small cell lung carcinoma patients: new evidences.

AUDITORÍA A LOS CRD ELECTRÓNICOS

SYSTEMS COMPUTERIZED IN THE DIRECTION OF CLINICAL RESEARCH

Biomarkers related to immunosenescence: relationships with therapy and survival in lung cancer patients

Páginas

Pizarra
53-7-2717933
Dirección general
53-7-2714335
cim@cim.sld.cu
Calle 15 esq. 216 S/N, Siboney, Playa, La Habana, Cuba. A.P 16040, La Habana 11600, Cuba.
Código Postal:
11 600
Apartado Postal:
16 040